Charlotte’s Web Holdings has always had significant involvement in furthering cannabis research. Its roots lie in cannabis as an alternative treatment, and the company has been at the forefront of some of the more important advances made in the field. It’s now going to launch a new study, in conjunction with the University of Colorado-Boulder, to explore the use of cannabis in treating sleep and anxiety using full-spectrum hemp formulations.
Charlotte’s Web announced the new research yesterday, explaining that it is collaborating with UC-Boulder’s REACH (Research and Education Addressing Cannabis and Health) Center to perform the study. They will use the company’s full-spectrum hemp products that contain cannabinol (CBN), cannabidiol (CBD) and low levels of tetrahydrocannabinol (THC) in order to test the impact of the products on anxiety and sleep quality.
“Charlotte’s Web is committed to advancing science on the benefits and safety of CBD and other hemp phytocannabinoids through rigorous scientific investigations such as this sleep and anxiety study,” said Tim Orr, Senior Vice President of Charlotte’s Web and President of its CW Labs division, which currently has more than a dozen scientific research studies underway. “We’re honored to team up with CU’s REACH Center to explore the potential impacts of full-spectrum hemp extract with CBD and CBN on anxiety and sleep quality.”
There hasn’t been a lot of published preclinical or clinical data on the use of phytocannabinoids in treating sleep or anxiety, except for research that has focused on either CBD or THC. Only anecdotal evidence exists to suggests that CBN could be a beneficial sleep aid, but in-depth studies like the one that Charlotte’s Web is going to conduct are missing. The company’s goal is to provide better scientific data to show how specific rations of different cannabinoids interact with the body using different delivery formats to help those suffering from sleep issues or anxiety combat their problems.